Friday, August 18, 2017
 
 
Company News: Page (1) of 1 - 03/20/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
LGC Maine Standards Announces Release of VALIDATE® HEPARIN Calibration Verification / Linearity Test Kit for IL ACL TOP® 500 Hemostasis Test Systems
 
(March 20, 2017)
LGC Maine Standards Announces Release of VALIDATE® HEPARIN Calibration Verification / Linearity Test Kit for IL ACL TOP® 500 Hemostasis Test Systems

LGC Maine Standards is pleased to announce its VALIDATE® HEPARIN calibration verification / linearity test kit has received US FDA 510(k) clearance for use on Instrumentation Laboratory ACL TOP® 500 hemostasis test systems. The VALIDATE® HEPARIN kit evaluates Heparin Anti-Xa activity in a human plasma matrix. Each VALIDATE® HEPARIN kit is prepared using CLSI's EP06-A recommended ?equal delta" method for linearity testing and is liquid, ready-to-use. Simply add the product from the dropper bottle directly into a sample cup and run in replicates.

Release of this product will allow clinical laboratories using Instrumentation Laboratory ACL TOP® 500 hemostasis test systems to complete their required Heparin calibration verification / linearity testing and maximize the reportable range while minimizing manual dilutions. The addition of VALIDATE® HEPARIN to the LGC Maine Standards expanding portfolio of products demonstrates a continued commitment to manufacture high-quality calibration verification / linearity products that meet industry needs.

LGC Maine Standards is located in Cumberland Foreside, Maine and manufactures VALIDATE® calibration verification / linearity test kits for over one hundred analytes, including General Chemistries, Urine Chemistries, Enzymes, Lipids, HbA1c, Therapeutic Drugs, Cardiac Markers, Thyroids, Serum Proteins, Vitamin D, Tumor Markers, Anemia, Fertility, Coagulation and Whole Blood.


LGC Maine Standards MSDRx® data reduction software is available at no charge for real-time data analysis or, in the United States, a laboratory can send their data to LGC Maine Standards where a technical specialist will complete the data analysis and return a report within five business days.

Contact: Maine Standards Company, LLC
221 US Route 1, Cumberland Foreside, ME 04110
1-207-892-1300 x73
aciccomancini(at)mainestandards(dot)com
http://www.mainestandards.com

###

About LGC
LGC is an international life sciences measurement and testing company with leading positions in growing markets. LGC provides a range of measurement products and services which underpin the safety, health and security of the public, including reference materials and proficiency testing, calibration verification / linearity testing, genomics reagents and instrumentation, and expert sample analysis and interpretation. LGC serves customers across a number of end markets including Pharmaceuticals, Agricultural Biotechnology, Food, Environment, Government and Academia.

LGC's headquarters are in London and the company employs over 2,000 people, operating out of 22 countries worldwide. Its operations are extensively accredited to international quality standards such as ISO/IEC 17025, GMP, GLP, ISO Guide 34, ISO/IEC 17043 and ISO 13485:2003.

With a history dating back to 1842, LGC has been home to the UK Government Chemist for more than 100 years and is the UK National Measurement Laboratory and Designated Institute for chemical and bio measurement. LGC was privatized in 1996 and is now owned by funds affiliated with KKR.

For more information, please visit http://www.lgcgroup.com

Read the full story at http://www.prweb.com/releases/2017/03/prweb14166541.htm.


Page: 1


Related Keywords:
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Medical Sector Contract Electronic Manufacturing Market shows lucrative growth CAGR of 8.8 % by 2022
  • Ascension Teams with Plug and Play Tech Center to Connect with Health and Wellness Startups
  • Global Sleep Apnea Devices Market to Grow at a CAGR of 7.8% by 2024 - Large Scale Benefits of Medical Devices is Driving Demand for Medical Platforms.
  • At 8+% CAGR Lateral Flow Assay Market Potentially Worth $8.24 Billion by 2022 Led by Asia-Pacific Region
  • UNITY Biotechnology Announces Extension of Series B Financing Bringing Total Round to $151 Million

    Cancer
  • argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017
  • Astronauts Showcase Space Art Created with Childhood Cancer Patients
  • Three Grant Funding Opportunities for Brain Tumor Research Funding Open Today
  • Kitov Pharmaceuticals Provides Corporate Update and Reports First Half 2017 Financial Results
  • ASPCA and the Petco Foundation Partner to Grant $1.5 Million to Dogs Playing For Life to Expand Life-Saving Playgroups Nationwide
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines